0001438133-23-000050.txt : 20230307 0001438133-23-000050.hdr.sgml : 20230307 20230307184127 ACCESSION NUMBER: 0001438133-23-000050 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230303 FILED AS OF DATE: 20230307 DATE AS OF CHANGE: 20230307 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BERGER DAVID B CENTRAL INDEX KEY: 0001422126 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36189 FILM NUMBER: 23714311 MAIL ADDRESS: STREET 1: 11045 ROSELLE STREET CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: TANDEM DIABETES CARE INC CENTRAL INDEX KEY: 0001438133 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 204327508 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 11075 ROSELLE STREET CITY: San Diego STATE: CA ZIP: 92121 BUSINESS PHONE: 858-366-6900 MAIL ADDRESS: STREET 1: 11075 ROSELLE STREET CITY: San Diego STATE: CA ZIP: 92121 4 1 wf-form4_167823247447992.xml FORM 4 X0306 4 2023-03-03 0 0001438133 TANDEM DIABETES CARE INC TNDM 0001422126 BERGER DAVID B C/O TANDEM DIABETES CARE, INC. 11075 ROSELLE STREET SAN DIEGO CA 92121 0 1 0 0 EVP & Chief Operating Officer Common Stock 2023-03-03 4 M 0 10000 18.86 A 13365 D Common Stock 2023-03-03 4 S 0 10000 41.1884 D 3365 D Common Stock 242 I Berger Family Trust Stock Option 18.86 2023-03-03 4 M 0 10000 18.86 A Common Stock 10000.0 0 D The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $41.16 to $41.24. The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold. The securities are held by the Berger Family Trust dated April 16, 2008. The options vested as to fifty (50%) of the underlying shares on 6/14/2019, and the remaining shares vested in twelve (12) equal monthly installments thereafter, subject to the terms of the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan (the "2013 Plan"). The expiration date for these options is 10 years from the date of grant. /s/ Rachel Malina, Attorney-in-Fact for David B. Berger 2023-03-07